Drugs -- Labeling -- Standards : Standardizing medication labels : confusing patients less : workshop summary / Lyla M. Hernandez, rapporteur ; Roundtable on Health Literacy, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
Drugs -- Law and legislation -- Colombia : Del junco al empaque : chamanismo, comercialización y regulaciones : configuraciones de la medicina indígena empaquetada en el altiplano cundiboyacense / Diego A. Garzon-Forero
Drugs -- Law and legislation -- Handbooks, manuals, etc : Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by governments. Pharmaceuticals / Department of Social and Ecominic Affairs
Drugs -- Law and legislation -- India : Contract research and manufacturing services (CRAMS) in India : the business, legal, regulatory and tax environment in the pharmaceutical and biotechnology sectors / Milind Antani and Gowree Gokhale
Drugs -- Law and legislation -- Japan : Competition law and policy in the Japanese pharmaceutical sector / Akira Negishi, Masako Wakui, Naoko Mariyama, editors
2022
1
Drugs -- Law and legislation -- Middle East : Pharmaceutical regulatory environment : challenges and opportunities in the Gulf Region / Reem K. Al-Essa, Mohammed Al-Rubaie, Stuart Walker, Sam Salek
Drugs -- Law and legislation -- United States -- Criminal provisions : Handbook of Federal narcotic and dangerous drug laws / prepared by Michael R. Sonnenreich, Deputy Chief Counsel ; Robert L. Bogomolny, Assistant Chief Counsel ; Robert J. Graham of the Office of Chief Counsel, Bureau of Narcotics and Dangerous Drugs, Department of Justice
1969
1
Drugs -- Law and legislation -- United States -- Decision making -- Congresses : Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : workshop summary / Denise Caruso, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies